Aquestive Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aquestive Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Aquestive Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $5.44M, a 5.94% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.44M -$343K -5.94% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.44M -$442K -7.51% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.56M +$346K +6.64% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $5.67M +$3.58M +171% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $5.78M +$3.46M +150% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $5.88M +$3.36M +133% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $5.21M +$2.49M +91.2% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $2.09M -$823K -28.2% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $2.31M -$788K -25.4% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $2.52M -$753K -23% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $2.73M -$723K -21% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.92M -$692K -19.2% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $3.1M -$662K -17.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $3.28M -$635K -16.2% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $3.45M +$3.45M Dec 31, 2020 10-K 2022-03-08
Q3 2020 $3.61M Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $3.76M Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $3.91M Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $0 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.